Stock Movers Home Depot Climbs, Pfizer Rises, Amer Sports Rallies on Earnings
May 20, 2025
Home Depot's shares surge despite a slight dip in sales, attributed to weather, but optimism remains as demand improves. Pfizer's stock climbs following a lucrative licensing deal with 3SBio, potentially earning them billions. Meanwhile, Amer Sports enjoys a boost after exceeding profit forecasts and reporting strong quarterly results. The episode highlights these market movements and their implications for investors.
AI Snips
Chapters
Transcript
Episode notes
Busy Weekend at Home Depot
- Lisa Mateo shared her personal experience shopping at Home Depot during a busy spring weekend.
- She noted the store was crowded, highlighting demand for smaller project supplies among consumers.
Weather Hits Sales, Small Projects Rise
- Home Depot's sales slowed due to bad weather but demand improved in March and April, maintaining yearly guidance.
- Smaller projects are boosting U.S. sales, while consumers postpone bigger jobs.
Pfizer's Big Cancer Drug Deal
- Pfizer secured a $6 billion global licensing deal with 3S Bio for cancer drug development outside China.
- This deal reflects a surge in big pharma's interest in Chinese-originated drug licensing in 2024.